Stock CGTX COGNITION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
1.95 USD +1.04% Intraday chart for Cognition Therapeutics, Inc. +5.98% +5.41%
04-12 Transcript : Cognition Therapeutics, Inc. - Special Call
03-26 Transcript : Cognition Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease
AQ
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
AQ
Transcript : Cognition Therapeutics, Inc. - Special Call
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
GL
Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024
AQ
Transcript : Cognition Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024
Cognition Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
GL
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
GL
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
AQ
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
GL
Cognition Therapeutics Prices $11.5 Million Stock Offering
MT
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
GL
Cognition Therapeutics Starts Public Offering; Shares Decline
MT
Cognition Therapeutics : Results of Operations and Financial Condition - Form 8-K
PU
Cognition Therapeutics, Inc. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2023
CI
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
GL
Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies
AQ
Cognition Therapeutics, Inc. Presents Analyses at AD/PD 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer?s Disease Studies
CI
Cognition Therapeutics to Present at the TD Cowen Health Care Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGTX Stock
  4. News Cognition Therapeutics, Inc.